Agony of choice-selecting chronic lymphocytic leukemia treatment in 2022
{{output}}
The treatment landscape of chronic lymphocytic leukemia (CLL) has undergone profound change in recent years. Targeted therapies have outnumbered chemotherapy-based treatment approaches demonstrating superior efficacy and tolerability profiles across nearly all... ...